v3.25.2
Consolidated Statements of Loss and Comprehensive Loss - CAD ($)
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
EXPENSES      
Consulting (Note 10) $ 160,341 $ 120,801 $ 405,138
Investor relations and promotion (Note 10) 1,440,910 851,614 157,983
Listing fee 26,000 54,184 0
Management and director fees (Note 10) 808,550 754,542 381,819
Office and miscellaneous 306,323 267,690 87,866
Property investigation costs 0 0 4,399
Professional fees 1,926,012 1,178,691 1,576,974
Share-based payments (Notes 9 and 10) 872,879 910,700 815,428
Transfer agent and filing fees 250,316 290,042 75,446
Travel 25,209 70,379 31,466
Loss before other items (5,816,540) (4,498,643) (3,536,519)
Change in fair value of derivatives (Note 9) 498,534 166,651 0
Finance income on sublease 0 1,314 8,879
Foreign exchange loss (43,504) (35,996) (29,423)
Gain on forgiveness of debt (Notes 7 and 16) 106,624 10,000 184,813
Gain on long-term investment 0 671 (5,100)
Gain on sublease 0 2,962 5,925
Gain on sale of property (Note 6) 0 0 3,500,000
Interest expense (Note 8) (97,359) (126,606) (104,031)
Equity share of loss – 19.95% (105,760) 0 0
Gain on spin-out transaction (Note 17) 1,914,814 0 0
Other income 176 0 0
Recovery of flow-through premium liability (Notes 9 and 15) 120,902 8,477 977,534
Tax penalties and interest (Note 13) (193,262) 0 0
Write-off of prepaid expenses 0 (1,000) (48,000)
Write off of short-term loans payable (Note 8) 0 0 2,500
Net (Loss) Income and Comprehensive (Loss) Income for the year $ (3,615,375) $ (4,472,170) $ 956,578
Basic (loss) earnings per common share (in CAD per share) $ (0.48) $ (0.99) $ 0.25
Diluted (loss) earnings per common share (in CAD per share) $ (0.48) $ (0.99) $ 0.24
Weighted average number of common shares outstanding - Basic (in shares) 7,512,279 4,518,348 3,836,323
Weighted average number of common shares outstanding – Diluted (in shares) 7,512,279 4,518,348 3,932,686
Share options 1 [member]      
EXPENSES      
Dilutive effect (in shares) 0 0 85,182
Dilutive warrants [member]      
EXPENSES      
Dilutive effect (in shares) 0 0 11,181